Nicoletta Colombo

机构：European Institute of Oncology, University of Milano-Bicocca · ORCID：0000-0003-2225-715X

发表论文 805 篇 · 总被引 56475 次 · h-index 102

代表论文

• The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201 (2025 · Future Oncology · 被引 1)
• Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma (2026 · Lung Cancer)
• Three-Dimensional Deep Learning Prediction of Cytoreduction Outcome Using Preoperative CT Scans: A Preliminary Internal Validation Study (2026 · International Journal of Gynecological Cancer)
• CO101 MEAN OVERALL SURVIVAL FROM THE PHASE 3 MIRASOL TRIAL OF MIRVETUXIMAB SORAVTANSINE VS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN WOMEN WITH FR?-HIGH PLATINUM-RESISTANT OVARIAN CANCER (GOG 3045/ENGOT-OV55; NCT04209855) (2026 · Value in Health)
• Somatic BRCA1 and BRCA2 detection in homologous recombination deficiency testing: concordance of four sequencing workflows with the Myriad myChoice companion diagnostic (2026 · International Journal of Gynecological Cancer)
• Predicting Residual Disease and Extent of Surgery After Neoadjuvant Chemotherapy for Ovarian Cancer: Do Models From The Primary Setting Apply? (2026 · SSRN Electronic Journal)